Study ID: TVP-1012/PM101
Study Title
- A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
Teva Identifier
- TVP-1012/PM101
ClinicalTrials.gov Identifier
- NCT00399477
Study Status
- Completed
Trial Condition(s)
- Parkinson's Disease
Interventions
- Drug: rasagiline mesylate |Drug: Rasagiline mesylate plus Mirapex | Drug: Rasagiline mesylate with Levodopa | Drug: Rasagiline mesylate with Requip
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 30 Years and older
Trial Duration
- 10/01/2006 - 07/01/2007
Phase
- Phase 4
Study Type
Interventional
